🕒 Tuesday 13 October 2026 Tue, 13 Oct 2026

Great Southern Mining has reported a run of high-grade gold intercepts at Golden Boulder, extending mineralisation across the northern 1.1 kilometres of a 3.5-kilometre trend. The exploration gains arrive alongside A$2.524 million in cash and a reported 1.13 quarters of funding at the quarter-end spending rate.

Stavely Minerals is testing smaller and potentially easier-to-fund development routes for Thursday’s Gossan after a large open-pit study delivered strong economics but demanded substantial upfront capital. The alternatives could reduce capital intensity, although the company expects they may produce lower NPVs.

Southern Palladium’s updated study has lifted the Bengwenyama project’s post-tax NPV to US$1.96 billion, driven by sharply improved chrome recovery and a stronger commodity price deck. The project still needs a definitive feasibility study, permits, funding and commercial offtake arrangements before those figures can be tested in development.

Prescient Therapeutics has reached the first planned review threshold in its PTX-100 Phase 2a lymphoma study, while a completed A$6.0 million raise extends funding beyond the December milestone. The review will assess safety and efficacy, but is not a study completion or a new clinical result.

Solstice Minerals has reported broad copper-gold intersections beyond Nanadie’s current resource boundary, including 64.1 metres at 0.94% copper and 91.4 metres at 0.97% copper. A spectacular silver interval adds intrigue, but its geometry and economic significance remain unresolved.

Many Peaks Minerals has reported a 188.9-metre gold intercept beneath the Ouarigue resource at its Ferké project in Côte d’Ivoire, including 46.75 metres at 7.02g/t and a narrow 109.8g/t interval. The results will feed into a resource update now under way, while regional drilling has opened additional targets south of Ouarigue.

The US FDA has supported six of seven elements NeuroScientific Biopharmaceuticals put forward for its planned StemSmart Phase 2 Crohn’s disease trial. The remaining issue is a manufacturing control for viral contamination, while trial commencement remains targeted for the end of 2026 and subject to further requirements.

Kinetiko Energy is preparing to submit a permit that could allow limited gas sales from its Brakfontein project in early 2027, while engineering, procurement and drilling plans advance in parallel. The company has also shortlisted three candidates for its next chief executive.

Elixinol Wellness has lifted combined hemp sales 12% to $6.41 million in the first nine months of 2026, while unaudited gross profit rose 41%. Two major grocery programs are now fully supplied through 2027, with Hemp Gold Protein due back at Costco in Australia and New Zealand.

American Tungsten & Antimony has produced one antimony ingot assaying 99.8% from US-mined material, meeting the highest ASTM B237 grade and exceeding the Regulus II specification. The result comes as the company pursues US government funding and offtake arrangements, although no commitments have been secured and AT4 does not yet control the relevant assets.

Macro Metals has secured approximately A$3.28 million through a placement and the proposed conversion of its chairman’s loan, funding drilling across iron ore, copper and gold assets. The raise also completes the acquisition of Yandi South, but much of the capital remains tied to exploration outcomes that are yet to be established.

Maronan Metals has secured firm commitments for a $20 million placement to expand drilling and bring forward engineering, permitting and metallurgical work at its Queensland project. The raise is conditional on shareholder approval, with Kinterra Capital set to lift its interest to 22.99%.

Astral Resources has intersected broad, high-grade gold below the current Theia resource pit shell while extending mineralisation about 150 metres south. The results strengthen the exploration case beneath the planned open pit, although a resource or reserve increase has not yet been announced.

Memphasys has reported record September-quarter invoiced revenue of A$211,000 as its Felix fertility device moves into more international markets. The commercial progress comes alongside A$3.5 million in funding, but the loan still requires shareholder approval for conversion into notes.

Rumble Resources has renewed attention on its Earaheedy zinc-lead-silver project, pointing to a 94Mt inferred resource and metallurgical work that produced a 61% zinc-plus-lead bulk concentrate. The company is now testing separate concentrates and seeking strategic partners, but the project remains short of a definitive development case.

Baby Bunting has reaffirmed its FY27 earnings and sales targets despite underlying comparable store sales growth moderating to 2.2% in the first 14 weeks. The retailer says its Store of the Future refurbishments are now delivering a 20% average sales uplift across 17 stores.

White Cliff Minerals has identified copper sulphides on a previously untested parallel structure mapped over 2.8km at its Rae Copper Project. Sulphides also appeared in all three northeast infill holes, but laboratory assays remain six to eight weeks away.

Orthocell says Remplir was placed successfully in five complex robotic prostatectomy cases, with no device-related complications reported over approximately 12 months. The preliminary results will guide a larger prospective trial ahead of a planned US expansion for the nerve repair product.

L1 Global Long Short Fund has opened the retail leg of a non-renounceable entitlement offer that could issue up to 216.9 million new shares at $1.76 each. Strong institutional demand has already raised about $100.9 million, but the retail component remains non-underwritten and final proceeds will depend on participation.

PainChek has expanded its Sabra relationship from two initial facilities to 23 US communities across five operators, covering 808 contracted memory care licences. The immediate test is whether those contracts become implemented recurring revenue by the end of 2026.

WiseTech Global’s FY26 annual report charts a year of extraordinary expansion, with revenue up 79% after the e2open acquisition and underlying EBITDA up 56%. But the stronger earnings base comes with heavier debt, a major workforce reset and unresolved regulatory risks.

EDU Holdings has lifted total enrolments 26% to a record 7,489, with Higher Education up 45% and now accounting for 88% of the group. The result also exposes a sharper divide: domestic and postgraduate demand is strengthening, while international VET enrolments continue to contract.

Sunstone Metals has expanded the Bramaderos gold-copper Mineral Resource Estimate by 72% to 6.2 million ounces of gold equivalent, with Indicated Resources rising 450% to 3.3Moz. The upgrade strengthens the basis for future mine studies, but remains an exploration-stage estimate with metallurgical and funding questions still to resolve.

Ionic Rare Earths has moved its Belfast magnet recycling project closer to construction while expanding into the United States through a proposed US$100 million joint venture. The progress comes with key funding, approvals and definitive agreements still outstanding.